share_log

Scotiabank Maintains Sector Perform on Janux Therapeutics, Raises Price Target to $62

Benzinga ·  Dec 4, 2024 23:39  · Ratings

Scotiabank analyst George Farmer maintains Janux Therapeutics (NASDAQ:JANX) with a Sector Perform and raises the price target from $42 to $62.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment